Daniel G. Welch's Insider Trades & SAST Disclosures
Daniel G. Welch's most recent trade in Structure Therapeutics Inc - ADR was a trade of 37,500 Share Option (right to buy) done . Disclosure was reported to the exchange on June 25, 2024.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Daniel G. Welch.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Structure Therapeutics Inc... | Daniel G. Welch | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jun 2024 | 37,500 | 37,500 | - | - | Share Option (right to buy) | |
| Ultragenyx Pharmaceutical ... | Daniel G. Welch | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jun 2024 | 9,900 | 9,900 | - | - | Stock Option (Right to Buy) | |
| Ultragenyx Pharmaceutical ... | Daniel G. Welch | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jun 2024 | 5,345 | 26,950 (0%) | 0% | 0 | Common Stock | |
| Nuvation Bio Inc - Ordinar... | Daniel G. Welch | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.64 per share. | 24 May 2024 | 366,744 | 659,947 | - | 1.6 | 601,460 | Class A Common Stock |
| Nuvation Bio Inc - Ordinar... | Daniel G. Welch | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 May 2024 | 366,744 | 0 | - | - | Stock Option (Right to Buy) | |
| Nuvation Bio Inc - Ordinar... | Daniel G. Welch | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 May 2024 | 293,203 | 19,547 | - | - | Stock Option (Right to Buy) | |
| Nuvation Bio Inc - Ordinar... | Daniel G. Welch | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.74 per share. | 24 May 2024 | 293,203 | 293,203 | - | 1.7 | 510,173 | Class A Common Stock |
| Prothena Corporation plc | Daniel G. Welch | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 May 2024 | 15,000 | 15,000 | - | - | Stock Option (Right to Buy) | |
| Prothena Corporation plc | G. Daniel Welch | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Feb 2024 | 132,000 | 132,000 | - | - | Stock Option (Right to Buy) | |
| Seagen Inc | Daniel G. Welch | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 135.63 per share. | 28 Aug 2023 | 1,812 | 10,109 (0%) | 0% | 135.6 | 245,762 | Common Stock |
| Seagen Inc | Daniel G. Welch | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Aug 2023 | 1,812 | 0 | - | - | Non-Qualified Stock Option (right to buy) | |
| Seagen Inc | Daniel G. Welch | Director | Sale of securities on an exchange or to another person at price $ 209.01 per share. | 28 Aug 2023 | 1,812 | 6,794 (0%) | 0% | 209.0 | 378,726 | Common Stock |
| Seagen Inc | Daniel G. Welch | Director | Sale of securities on an exchange or to another person at price $ 209.08 per share. | 28 Aug 2023 | 1,610 | 10,725 (0%) | 0% | 209.1 | 336,619 | Common Stock |
| Seagen Inc | Daniel G. Welch | Director | Sale of securities on an exchange or to another person at price $ 209.16 per share. | 28 Aug 2023 | 1,503 | 8,606 (0%) | 0% | 209.2 | 314,367 | Common Stock |
| Ultragenyx Pharmaceutical ... | Daniel G. Welch | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jun 2023 | 7,110 | 7,110 | - | - | Stock Option (Right to Buy) | |
| Ultragenyx Pharmaceutical ... | Daniel G. Welch | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jun 2023 | 3,860 | 21,605 (0%) | 0% | 0 | Common Stock | |
| Seagen Inc | Daniel G. Welch | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 May 2023 | 2,044 | 8,297 (0%) | 0% | 0 | Common Stock | |
| Nuvation Bio Inc - Ordinar... | Daniel G. Welch | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 May 2023 | 366,744 | 366,744 | - | - | Stock Option (Right to Buy) | |
| Seagen Inc | Daniel G. Welch | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 May 2023 | 1,864 | 1,812 | - | - | Non-Qualified Stock Option (right to buy) | |
| Seagen Inc | Daniel G. Welch | Director | Sale of securities on an exchange or to another person at price $ 200.02 per share. | 15 May 2023 | 1,864 | 6,253 (0%) | 0% | 200.0 | 372,837 | Common Stock |
| Seagen Inc | Daniel G. Welch | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 135.63 per share. | 15 May 2023 | 1,864 | 8,117 (0%) | 0% | 135.6 | 252,814 | Common Stock |
| Seagen Inc | Daniel G. Welch | Director | Sale of securities on an exchange or to another person at price $ 200.07 per share. | 01 May 2023 | 5,835 | 12,335 (0%) | 0% | 200.1 | 1,167,408 | Common Stock |
| Seagen Inc | Daniel G. Welch | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 64.38 per share. | 01 May 2023 | 5,150 | 12,049 (0%) | 0% | 64.4 | 331,557 | Common Stock |
| Seagen Inc | Daniel G. Welch | Director | Sale of securities on an exchange or to another person at price $ 200.04 per share. | 01 May 2023 | 5,150 | 6,899 (0%) | 0% | 200.0 | 1,030,206 | Common Stock |
| Seagen Inc | Daniel G. Welch | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 May 2023 | 5,150 | 1,888 | - | - | Non-Qualified Stock Option (right to buy) | |
| Seagen Inc | Daniel G. Welch | Director | Sale of securities on an exchange or to another person at price $ 200.06 per share. | 01 May 2023 | 4,890 | 18,170 (0%) | 0% | 200.1 | 978,293 | Common Stock |
| Seagen Inc | Daniel G. Welch | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 May 2023 | 3,462 | 0 | - | - | Non-Qualified Stock Option (right to buy) | |
| Seagen Inc | Daniel G. Welch | Director | Sale of securities on an exchange or to another person at price $ 200.10 per share. | 01 May 2023 | 3,462 | 6,604 (0%) | 0% | 200.1 | 692,746 | Common Stock |
| Seagen Inc | Daniel G. Welch | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 147.50 per share. | 01 May 2023 | 3,462 | 10,066 (0%) | 0% | 147.5 | 510,645 | Common Stock |
| Seagen Inc | Daniel G. Welch | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 May 2023 | 3,171 | 0 | - | - | Non-Qualified Stock Option (right to buy) | |
| Seagen Inc | Daniel G. Welch | Director | Sale of securities on an exchange or to another person at price $ 200.05 per share. | 01 May 2023 | 3,171 | 6,604 (0%) | 0% | 200.1 | 634,359 | Common Stock |
| Seagen Inc | Daniel G. Welch | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 160.33 per share. | 01 May 2023 | 3,171 | 9,775 (0%) | 0% | 160.3 | 508,406 | Common Stock |
| Seagen Inc | Daniel G. Welch | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 May 2023 | 1,990 | 0 | - | - | Non-Qualified Stock Option (right to buy) | |
| Seagen Inc | Daniel G. Welch | Director | Sale of securities on an exchange or to another person at price $ 200.12 per share. | 01 May 2023 | 1,990 | 6,899 (0%) | 0% | 200.1 | 398,239 | Common Stock |
| Seagen Inc | Daniel G. Welch | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 56.77 per share. | 01 May 2023 | 1,990 | 8,889 (0%) | 0% | 56.8 | 112,972 | Common Stock |
| Seagen Inc | Daniel G. Welch | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 May 2023 | 1,888 | 0 | - | - | Non-Qualified Stock Option (right to buy) | |
| Seagen Inc | Daniel G. Welch | Director | Sale of securities on an exchange or to another person at price $ 200.05 per share. | 01 May 2023 | 1,888 | 6,604 (0%) | 0% | 200.0 | 377,694 | Common Stock |
| Seagen Inc | Daniel G. Welch | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 64.38 per share. | 01 May 2023 | 1,888 | 8,492 (0%) | 0% | 64.4 | 121,549 | Common Stock |
| Seagen Inc | Daniel G. Welch | Director | Sale of securities on an exchange or to another person at price $ 200.07 per share. | 01 May 2023 | 351 | 6,253 (0%) | 0% | 200.1 | 70,225 | Common Stock |
| Seagen Inc | Daniel G. Welch | Director | Sale of securities on an exchange or to another person at price $ 200.06 per share. | 01 May 2023 | 295 | 6,604 (0%) | 0% | 200.1 | 59,018 | Common Stock |
| Seagen Inc | Daniel G. Welch | Director | Sale of securities on an exchange or to another person at price $ 200.05 per share. | 15 Mar 2023 | 2,037 | 7,219 (0%) | 0% | 200.1 | 407,502 | Common Stock |
| Seagen Inc | Daniel G. Welch | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Mar 2023 | 2,037 | 995 | - | - | Non-Qualified Stock Option (right to buy) | |
| Seagen Inc | Daniel G. Welch | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 38.82 per share. | 15 Mar 2023 | 2,037 | 9,256 (0%) | 0% | 38.8 | 79,076 | Common Stock |
| Seagen Inc | Daniel G. Welch | Director | Sale of securities on an exchange or to another person at price $ 200.05 per share. | 15 Mar 2023 | 1,246 | 23,060 (0%) | 0% | 200.0 | 249,262 | Common Stock |
| Seagen Inc | Daniel G. Welch | Director | Sale of securities on an exchange or to another person at price $ 200.05 per share. | 15 Mar 2023 | 320 | 6,899 (0%) | 0% | 200.1 | 64,016 | Common Stock |
| Seagen Inc | Daniel G. Welch | Director | Sale of securities on an exchange or to another person at price $ 200.20 per share. | 13 Mar 2023 | 8,210 | 25,575 (0%) | 0% | 200.2 | 1,643,642 | Common Stock |
| Seagen Inc | Daniel G. Welch | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Mar 2023 | 7,629 | 0 | - | - | Non-Qualified Stock Option (right to buy) | |
| Seagen Inc | Daniel G. Welch | Director | Sale of securities on an exchange or to another person at price $ 200.30 per share. | 13 Mar 2023 | 7,629 | 15,407 (0%) | 0% | 200.3 | 1,528,089 | Common Stock |
| Seagen Inc | Daniel G. Welch | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 39.94 per share. | 13 Mar 2023 | 7,629 | 23,036 (0%) | 0% | 39.9 | 304,702 | Common Stock |
| Seagen Inc | Daniel G. Welch | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Mar 2023 | 5,758 | 3,502 | - | - | Non-Qualified Stock Option (right to buy) | |
| Seagen Inc | Daniel G. Welch | Director | Sale of securities on an exchange or to another person at price $ 200.06 per share. | 13 Mar 2023 | 5,758 | 7,219 (0%) | 0% | 200.1 | 1,151,945 | Common Stock |
| Seagen Inc | Daniel G. Welch | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 38.82 per share. | 13 Mar 2023 | 5,758 | 15,407 (0%) | 0% | 38.8 | 223,526 | Common Stock |
| Seagen Inc | Daniel G. Welch | Director | Sale of securities on an exchange or to another person at price $ 200.20 per share. | 13 Mar 2023 | 2,098 | 13,309 (0%) | 0% | 200.2 | 420,020 | Common Stock |
| Seagen Inc | Daniel G. Welch | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Mar 2023 | 1,348 | 7,629 | - | - | Non-Qualified Stock Option (right to buy) | |
| Seagen Inc | Daniel G. Welch | Director | Sale of securities on an exchange or to another person at price $ 201.53 per share. | 13 Mar 2023 | 1,348 | 15,407 (0%) | 0% | 201.5 | 271,662 | Common Stock |
| Seagen Inc | Daniel G. Welch | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 39.94 per share. | 13 Mar 2023 | 1,348 | 16,755 (0%) | 0% | 39.9 | 53,839 | Common Stock |
| Seagen Inc | Daniel G. Welch | Director | Sale of securities on an exchange or to another person at price $ 201.53 per share. | 13 Mar 2023 | 808 | 24,767 (0%) | 0% | 201.5 | 162,836 | Common Stock |
| Seagen Inc | Daniel G. Welch | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Mar 2023 | 470 | 3,032 | - | - | Non-Qualified Stock Option (right to buy) | |
| Seagen Inc | Daniel G. Welch | Director | Sale of securities on an exchange or to another person at price $ 200.00 per share. | 13 Mar 2023 | 470 | 12,977 (0%) | 0% | 200 | 94,000 | Common Stock |
| Seagen Inc | Daniel G. Welch | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 38.82 per share. | 13 Mar 2023 | 470 | 13,447 (0%) | 0% | 38.8 | 18,245 | Common Stock |
| Seagen Inc | Daniel G. Welch | Director | Sale of securities on an exchange or to another person at price $ 200.00 per share. | 13 Mar 2023 | 288 | 24,306 (0%) | 0% | 200 | 57,600 | Common Stock |
| Seagen Inc | Daniel G. Welch | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Mar 2023 | 283 | 8,977 | - | - | Non-Qualified Stock Option (right to buy) | |
| Seagen Inc | Daniel G. Welch | Director | Sale of securities on an exchange or to another person at price $ 202.36 per share. | 13 Mar 2023 | 283 | 15,407 (0%) | 0% | 202.4 | 57,268 | Common Stock |
| Seagen Inc | Daniel G. Welch | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 39.94 per share. | 13 Mar 2023 | 283 | 15,690 (0%) | 0% | 39.9 | 11,303 | Common Stock |
| Seagen Inc | Daniel G. Welch | Director | Sale of securities on an exchange or to another person at price $ 201.53 per share. | 13 Mar 2023 | 214 | 13,095 (0%) | 0% | 201.5 | 43,127 | Common Stock |
| Seagen Inc | Daniel G. Welch | Director | Sale of securities on an exchange or to another person at price $ 202.36 per share. | 13 Mar 2023 | 173 | 24,594 (0%) | 0% | 202.4 | 35,008 | Common Stock |
| Seagen Inc | Daniel G. Welch | Director | Sale of securities on an exchange or to another person at price $ 200.00 per share. | 13 Mar 2023 | 74 | 12,977 (0%) | 0% | 200 | 14,800 | Common Stock |
| Seagen Inc | Daniel G. Welch | Director | Sale of securities on an exchange or to another person at price $ 202.34 per share. | 13 Mar 2023 | 44 | 13,051 (0%) | 0% | 202.3 | 8,903 | Common Stock |
| Ultragenyx Pharmaceutical ... | Daniel G. Welch | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jun 2022 | 6,245 | 6,245 | - | - | Stock Option (Right to Buy) | |
| Ultragenyx Pharmaceutical ... | Daniel G. Welch | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jun 2022 | 3,300 | 17,745 (0%) | 0% | 0 | Common Stock | |
| Nuvation Bio Inc - Ordinar... | Daniel G. Welch | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 May 2022 | 140,713 | 140,713 | - | - | Stock Option (Right to Buy) | |
| Seagen Inc | Daniel G. Welch | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 May 2022 | 3,676 | 3,676 | - | - | Non-Qualified Stock Option (right to buy) | |
| Seagen Inc | Daniel G. Welch | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 May 2022 | 1,503 | 9,649 (0%) | 0% | 0 | Common Stock | |
| Ultragenyx Pharmaceutical ... | Daniel G. Welch | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jun 2021 | 4,125 | 4,125 | - | - | Stock Option (Right to Buy) | |
| Ultragenyx Pharmaceutical ... | Daniel G. Welch | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Jun 2021 | 2,145 | 14,445 (0%) | 0% | 0 | Common Stock | |
| Seagen Inc | Daniel G. Welch | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 May 2021 | 3,462 | 3,462 | - | - | Non-Qualified Stock Option (right to buy) | |
| Seagen Inc | Daniel G. Welch | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 May 2021 | 1,402 | 41,931 (0%) | 0% | 0 | Common Stock | |
| Seagen Inc | Daniel G. Welch | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Nov 2020 | 14,500 | 0 | - | - | Non-Qualified Stock Option (right to buy) | |
| Seagen Inc | Daniel G. Welch | Director | Sale of securities on an exchange or to another person at price $ 165.06 per share. | 02 Nov 2020 | 14,500 | 56,598 (0%) | 0% | 165.1 | 2,393,370 | Common Stock |
| Seagen Inc | Daniel G. Welch | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 19.02 per share. | 02 Nov 2020 | 14,500 | 71,098 (0%) | 0% | 19.0 | 275,790 | Common Stock |
| Seagen Inc | Daniel G. Welch | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Nov 2020 | 9,518 | 0 | - | - | Non-Qualified Stock Option (right to buy) | |
| Seagen Inc | Daniel G. Welch | Director | Sale of securities on an exchange or to another person at price $ 165.72 per share. | 02 Nov 2020 | 9,518 | 56,598 (0%) | 0% | 165.7 | 1,577,323 | Common Stock |
| Seagen Inc | Daniel G. Welch | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 20.06 per share. | 02 Nov 2020 | 9,518 | 66,116 (0%) | 0% | 20.1 | 190,931 | Common Stock |
| Seagen Inc | Daniel G. Welch | Director | Sale of securities on an exchange or to another person at price $ 164.61 per share. | 02 Nov 2020 | 9,250 | 47,348 (0%) | 0% | 164.6 | 1,522,643 | Common Stock |
| Seagen Inc | Daniel G. Welch | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 34.25 per share. | 02 Nov 2020 | 8,750 | 65,348 (0%) | 0% | 34.3 | 299,688 | Common Stock |
| Seagen Inc | Daniel G. Welch | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Nov 2020 | 8,750 | 0 | - | - | Non-Qualified Stock Option (right to buy) | |
| Seagen Inc | Daniel G. Welch | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Nov 2020 | 8,750 | 0 | - | - | Non-Qualified Stock Option (right to buy) | |
| Seagen Inc | Daniel G. Welch | Director | Sale of securities on an exchange or to another person at price $ 167.34 per share. | 02 Nov 2020 | 8,750 | 56,598 (0%) | 0% | 167.3 | 1,464,225 | Common Stock |
| Seagen Inc | Daniel G. Welch | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 36.70 per share. | 02 Nov 2020 | 8,750 | 65,348 (0%) | 0% | 36.7 | 321,125 | Common Stock |
| Seagen Inc | Daniel G. Welch | Director | Sale of securities on an exchange or to another person at price $ 168.24 per share. | 02 Nov 2020 | 8,750 | 56,598 (0%) | 0% | 168.2 | 1,472,100 | Common Stock |
| Seagen Inc | Daniel G. Welch | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Nov 2020 | 7,982 | 9,518 | - | - | Non-Qualified Stock Option (right to buy) | |
| Seagen Inc | Daniel G. Welch | Director | Sale of securities on an exchange or to another person at price $ 166.70 per share. | 02 Nov 2020 | 7,982 | 56,598 (0%) | 0% | 166.7 | 1,330,599 | Common Stock |
| Seagen Inc | Daniel G. Welch | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 20.06 per share. | 02 Nov 2020 | 7,982 | 64,580 (0%) | 0% | 20.1 | 160,119 | Common Stock |
| Ultragenyx Pharmaceutical ... | Daniel G. Welch | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jun 2020 | 4,250 | 4,250 | - | - | Stock Option (Right to Buy) | |
| Ultragenyx Pharmaceutical ... | Daniel G. Welch | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jun 2020 | 2,550 | 12,300 (0%) | 0% | 0 | Common Stock | |
| Intercept Pharmaceuticals Inc | Daniel G. Welch | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 May 2020 | 2,966 | 2,966 | - | - | Option to Purchase Common Stock | |
| Intercept Pharmaceuticals Inc | Daniel G. Welch | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 May 2020 | 1,595 | 8,060 (0%) | 0% | 0 | Common Stock | |
| Seagen Inc | Daniel G. Welch | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 May 2020 | 3,171 | 3,171 | - | - | Non-Qualified Stock Option (right to buy) | |
| Seagen Inc | Daniel G. Welch | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 May 2020 | 1,335 | 56,598 (0%) | 0% | 0 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges